Purchase Order 75N94024P00276
Award Date 5/13/24
Potential Completion Date 9/9/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price Purchase Order to Synthego Corporation, a self-certified small disadvantaged business, for the delivery of KNOCKIN-SMALL, CELL CLONE, IMMORTALIZED with a potential value of $12,950.00. This order is part of Synthego's extensive portfolio of federal contracts to provide gene editing products, cell line engineering, and research support services...
- This is a $25,150.00 firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR genome engineering and related services to support biomedical research efforts across multiple NIH institutes. Synthego specializes in custom cell line development, gene...
- The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a firm-fixed-price purchase order contract to Synthego Corporation, a self-certified small disadvantaged business, to create genetically modified cell lines. The $36,300.03 contract requires Synthego to deliver two homozygous and two heterozygous POLR3B cell line clones, as well as two homozygous and two heterozygous POLR3E cell line clones, all derived from...
- This is a $33,750 firm-fixed price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Synthego Corporation, a self-certified small disadvantaged business manufacturer of gene editing products. The contract is for the provision of "SYTHEGO - KNOCK-IN AND KNOCK-OUT CELL CLONES" services to support biomedical research efforts across various government agencies. This is not a set-aside contract. Synthego has...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a $14,653 firm fixed price purchase order to Synthego Corporation, doing business as Synthego Corp, located in Redwood City, California. The contract is for services related to endogenous CLN3 1-kb deletion and will run from July 27, 2023 through July 26, 2024. As part of its mission to ensure the health, safety and well-being of children and families, the NICHD conducts research into human...
- This is a $146,665.75 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of goods. The contract was not set aside. Synthego, headquartered in Redwood City, California, is providing genome engineering solutions, including cell line engineering, CRISPR libraries, and other biological...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order contract to Synthego Corporation, a self-certified small disadvantaged business, for $188,840.00 to provide gene editing services. The contract is for the delivery of GMP-like CRISPRevolution modified single guide RNA (mod-sgRNA) sequences to support ongoing research within the LCIM program. The agency determined Synthego to...
- This federal contract award, valued at $22,825.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH). The contract was awarded to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products based in Redwood City, California. The contract is for the delivery of KNOCKIN-SMALL, CELL CLONE, IPSC, SYNTHEGO SUPPLIED services, which likely support NCATS'...
- This federal contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Center for Advancing Translational Sciences to Synthego Corporation, a self-certified small disadvantaged business, for high-throughput screening to identify modulators of the expression of human HIF1 and HIF2. The firm fixed price purchase order, valued at $22,650.00, will support genetic research at Synthego's facilities in Redwood City, California through...
- This is a federal contract award by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products based in Redwood City, California. The contract is a $46,600 firm fixed-price purchase order with a completion date of November 15, 2020. The contract does not have a set-aside designation. Synthego specializes in providing genome engineering solutions, including...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development (NICHD) awarded a Firm Fixed Price purchase order to Synthego Corporation, a self-certified small disadvantaged business, for the provision of custom knockin cell clones. The contract has a potential value of $11,450.00 and a completion date of September 9, 2024. Synthego Corporation is a leading provider of genome engineering solutions and has been awarded over 30 prime federal contracts with various NIH institutes for a wide range of gene editing products and research support services. This contract does not have a set-aside designation.
Generated 5/9/24, 11:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 5/8/24 |